Capricor Therapeutics, Inc. (FRA:4LN2)

Capricor Therapeutics Revenue

Capricor Therapeutics had revenue of $22.26M USD in the twelve months ending September 30, 2025, down -52.08% year-over-year. In the year 2024, Capricor Therapeutics had annual revenue of $44.54M, down -11.55%.

• Revenue (ttm): $22.26M
• Revenue Growth: -52.08%
• P/S Ratio: 27.57
• Revenue / Employee: $139.13K
• Employees: 160
• Market Cap: 261.52M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	44.54M	-5.82M	-11.55%
Dec 31, 2023	50.36M	45.25M	886.81%
Dec 31, 2022	5.10M	4.61M	941.85%
Dec 31, 2021	489.80K	-130.70K	-21.06%
Dec 31, 2020	620.50K	-1.39M	-69.13%
Dec 31, 2019	2.01M	-1.33M	-39.87%
Dec 31, 2018	3.34M	-1.99M	-37.32%
Dec 31, 2017	5.33M	1.33M	33.36%
Dec 31, 2016	4.00M	-1.52M	-27.53%
Dec 31, 2015	5.52M	730.95K	15.27%
Dec 31, 2014	4.79M	102.50K	2.19%
Dec 31, 2013	4.68M	2.79M	146.70%
Dec 31, 2012	1.90M	544.26K	40.18%
Dec 31, 2011	1.35M	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	101.40K	-	-